Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.
Connolly CM, Teles M, Frey S, Boyarsky BJ, Alejo JL, Werbel WA, Albayda J, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ. Connolly CM, et al. Among authors: teles m. Ann Rheum Dis. 2022 Feb;81(2):291-293. doi: 10.1136/annrheumdis-2021-221206. Epub 2021 Sep 7. Ann Rheum Dis. 2022. PMID: 34493492 Free PMC article. No abstract available.
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.
Connolly CM, Chiang TP, Boyarsky BJ, Ruddy JA, Teles M, Alejo JL, Massie A, Werbel WA, Shah AA, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ. Connolly CM, et al. Among authors: teles m. Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23. Ann Rheum Dis. 2022. PMID: 34556484 Free PMC article. No abstract available.
Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination.
Frey S, Connolly CM, Chiang TP, Teles M, Alejo JL, Boyarsky BJ, Christopher-Stine L, Werbel WA, Segev DL, Paik JJ. Frey S, et al. Among authors: teles m. Lancet Rheumatol. 2021 Nov;3(11):e753-e754. doi: 10.1016/S2665-9913(21)00282-4. Epub 2021 Sep 28. Lancet Rheumatol. 2021. PMID: 34725649 Free PMC article. No abstract available.
Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease.
Frey S, Chiang TP, Connolly CM, Teles M, Alejo JL, Boyarsky BJ, Christopher-Stine L, Werbel WA, Massie AB, Segev DL, Paik JJ. Frey S, et al. Among authors: teles m. Lancet Rheumatol. 2022 Apr;4(4):e241-e243. doi: 10.1016/S2665-9913(21)00417-3. Epub 2022 Jan 18. Lancet Rheumatol. 2022. PMID: 35072108 Free PMC article. No abstract available.
Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases.
Connolly CM, Chiang TP, Teles M, Frey S, Alejo JL, Massie A, Shah AA, Albayda J, Christopher-Stine L, Werbel WA, Segev DL, Paik JJ. Connolly CM, et al. Among authors: teles m. Lancet Rheumatol. 2022 Jun;4(6):e382-e384. doi: 10.1016/S2665-9913(22)00065-0. Epub 2022 Mar 29. Lancet Rheumatol. 2022. PMID: 35368386 Free PMC article. No abstract available.
207 results